Ann de Wees Allen®, the inventor and Patent-holder of ArgMatrix®,
was the first scientist to discover a safe and effective Isoform
Pathway for L-arginine via inclusion of a “Blind Amino Acid®
this research, spanning over 25 years, Dr. Allen received
the first glycemic patent ever awarded worldwide, (named Breakthrough
Product of the Year by Success magazine) and the first patent
on L-arginine attached to a Blind Amino Acid Rider.
research resulted in the only long-term proven safe and efficacious
form of L-arginine, which has been validated by independent
authorities, as safe and legal for use by professional and
competitive athletes in all fields.